Literature DB >> 28450073

Cerebral magnetic resonance changes associated with fibromyalgia syndrome.

Iñigo Murga1, Virginia Guillen2, José-Vicente Lafuente3.   

Abstract

Fibromyalgia syndrome is a chronic disease, of unknown origin, whose diagnostic criteria were established in 1990 by the American College of Rheumatology. New criteria were proposed in 2010 that have not yet been validated. It is characterized by a generalized chronic musculoskeletal pain, accompanied by hyperalgesia and allodynia, as well as other motor, vegetative, cognitive and affective symptoms and signs. We have reviewed a set of studies with cerebral magnetic resonance (morphometry, connectivity and spectroscopy) that refer to changes in areas involved in pain processing. Modifications in gray and white matter volume, as well as in levels of N-acetylaspartate, choline or glutamate, among other metabolites, have been observed in the hippocampus, insula, prefrontal and cingular cortex. Neuroradiological findings are nonspecific and similar to those found in other examples of chronic pain. An increase in the sample size and a standardized methodology would facilitate comparison, allowing the drawing of general conclusions.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Brain magnetic resonance; Conectividad; Connectivity; Espectroscopia; Fibromyalgia syndrome; Morfometría; Morphometry; Resonancia magnética cerebral; Spectroscopy; Síndrome de fibromialgia

Mesh:

Year:  2017        PMID: 28450073     DOI: 10.1016/j.medcli.2017.01.034

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  8 in total

1.  Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Authors:  Shani Zilberman-Itskovich; Merav Catalogna; Efrat Sasson; Karin Elman-Shina; Amir Hadanny; Erez Lang; Shachar Finci; Nir Polak; Gregory Fishlev; Calanit Korin; Ran Shorer; Yoav Parag; Marina Sova; Shai Efrati
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

2.  Can neural markers be used for fibromyalgia clinical management?

Authors:  Luis Castelo-Branco; Alejandra Cardenas-Rojas; Kevin Pacheco-Barrios; Paulo E P Teixeira; Paola Gonzalez-Mego; Karen Vasquez-Avila; Pablo Costa Cortez; Anna Marduy; Ingrid Rebello-Sanchez; Joao Parente; Sammer Marzouk; Felipe Fregni
Journal:  Princ Pract Clin Res       Date:  2022-04-24

3.  Metabolomics and psychological features in fibromyalgia and electromagnetic sensitivity.

Authors:  Cristina Piras; Stella Conte; Monica Pibiri; Giacomo Rao; Sandro Muntoni; Vera Piera Leoni; Gabriele Finco; Luigi Atzori
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

4.  Impact of Fibromyalgia in the Hippocampal Subfields Volumes of Women-An MRI Study.

Authors:  Juan Luis Leon-Llamas; Santos Villafaina; Alvaro Murillo-Garcia; Narcis Gusi
Journal:  Int J Environ Res Public Health       Date:  2021-02-06       Impact factor: 3.390

5.  Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).

Authors:  Ariadna Colomer-Carbonell; Juan P Sanabria-Mazo; Halbert Hernández-Negrín; Xavier Borràs; Carlos Suso-Ribera; Azucena García-Palacios; Jordi Muchart; Josep Munuera; Francesco D'Amico; Michael Maes; Jarred W Younger; Albert Feliu-Soler; Antoni Rozadilla-Sacanell; Juan V Luciano
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 2.692

6.  Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms.

Authors:  Cristina Muñoz Ladrón de Guevara; Gustavo A Reyes Del Paso; María José Fernández Serrano; Casandra I Montoro
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

7.  Electrophysiological indices of pain expectation abnormalities in fibromyalgia patients.

Authors:  Paloma Barjola; Irene Peláez; David Ferrera; José Luis González-Gutiérrez; Lilian Velasco; Cecilia Peñacoba-Puente; Almudena López-López; Roberto Fernandes-Magalhaes; Francisco Mercado
Journal:  Front Hum Neurosci       Date:  2022-09-30       Impact factor: 3.473

8.  Effectiveness of a multicomponent treatment versus conventional treatment in patients with fibromyalgia: Study protocol.

Authors:  Felipe Araya-Quintanilla; Héctor Gutiérrez-Espinoza; María Jesús Muñoz-Yánez; Iván Cavero-Redondo; Celia Álvarez-Bueno; Vicente Martinez-Vizcaíno
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.